Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$175M |
| 2 |
Intel
INTC
|
+$154M |
| 3 |
Amazon
AMZN
|
+$115M |
| 4 |
IBM
IBM
|
+$97.2M |
| 5 |
Prologis
PLD
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
GGP
GGP Inc.
GGP
|
+$135M |
| 3 |
TSMC
TSM
|
+$111M |
| 4 |
DCT
DCT Industrial Trust Inc.
DCT
|
+$81.8M |
| 5 |
XL
XL Group Ltd.
XL
|
+$59.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.59% |
| 2 | Financials | 14.04% |
| 3 | Healthcare | 13.2% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1951
DELISTED
Faro Technologies
FARO
| $5.98M | ﹤0.01% |
92,940
+4,808
| +5% | +$306K |
|
1952
Tompkins Financial
TMP
$1.44B
| $5.98M | ﹤0.01% |
73,655
+2,982
| +4% | +$258K |
|
|
NEX
1953
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $5.98M | ﹤0.01% |
483,400
-13,904
| -3% | -$179K |
|
|
ESPR
1954
DELISTED
Esperion Therapeutics
ESPR
| $5.97M | ﹤0.01% |
134,536
+23,147
| +21% | +$1.06M |
|
|
NTRI
1955
DELISTED
NutriSystem, Inc.
NTRI
| $5.94M | ﹤0.01% |
160,372
+11,260
| +8% | +$435K |
|
|
BHVN
1956
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.93M | ﹤0.01% |
158,009
+19,254
| +14% | +$708K |
|
1957
Financial Institutions
FISI
$825M
| $5.91M | ﹤0.01% |
188,045
+15,041
| +9% | +$486K |
|
|
AIMT
1958
DELISTED
Aimmune Therapeutics
AIMT
| $5.88M | ﹤0.01% |
215,577
+8,322
| +4% | +$235K |
|
|
SEND
1959
DELISTED
SendGrid, Inc.
SEND
| $5.87M | ﹤0.01% |
159,655
+104,155
| +188% | +$3.29M |
|
1960
AngioDynamics
ANGO
$651M
| $5.86M | ﹤0.01% |
269,692
-16,505
| -6% | -$367K |
|
|
HSII
1961
DELISTED
Heidrick & Struggles
HSII
| $5.86M | ﹤0.01% |
173,087
+59,997
| +53% | +$2.34M |
|
1962
Griffon
GFF
$4.75B
| $5.86M | ﹤0.01% |
362,574
+39,423
| +12% | +$704K |
|
1963
NeoGenomics
NEO
$2.11B
| $5.85M | ﹤0.01% |
381,108
+82,066
| +27% | +$1.13M |
|
|
CONN
1964
DELISTED
Conn's Inc.
CONN
| $5.83M | ﹤0.01% |
164,807
+11,661
| +8% | +$417K |
|
|
EGRX
1965
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.8M | ﹤0.01% |
83,669
+35,569
| +74% | +$2.7M |
|
|
KEM
1966
DELISTED
KEMET Corporation
KEM
| $5.79M | ﹤0.01% |
312,395
+41,831
| +15% | +$1.03M |
|
1967
SolarEdge
SEDG
$1.97B
| $5.79M | ﹤0.01% |
153,867
+27,462
| +22% | +$1.32M |
|
1968
CytomX Therapeutics
CTMX
$760M
| $5.78M | ﹤0.01% |
312,419
+76,493
| +32% | +$1.74M |
|
1969
Virtus Investment Partners
VRTS
$1.12B
| $5.77M | ﹤0.01% |
50,707
+8,728
| +21% | +$1.11M |
|
1970
ZTO Express
ZTO
$17.6B
| $5.76M | ﹤0.01% |
347,708
+30,063
| +9% | +$579K |
|
1971
RE/MAX Holdings
RMAX
$263M
| $5.76M | ﹤0.01% |
129,825
+33,519
| +35% | +$1.67M |
|
|
NVTA
1972
DELISTED
Invitae Corporation
NVTA
| $5.75M | ﹤0.01% |
343,527
+20,818
| +6% | +$237K |
|
|
IVC
1973
DELISTED
Invacare Corporation
IVC
| $5.73M | ﹤0.01% |
393,931
-1,272
| -0.3% | -$21.1K |
|
1974
Seaboard Corp
SEB
$4.02B
| $5.7M | ﹤0.01% |
1,535
+107
| +7% | +$399K |
|
1975
Workiva
WK
$3.7B
| $5.67M | ﹤0.01% |
143,646
+11,783
| +9% | +$366K |
|
Similar funds
Charles Schwab's Q3 2018 Portfolio in Review
As of Q3 2018, Charles Schwab held 3,187 positions worth $150B, up 9.4% from $137B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab deployed $4.72B of net new capital in Q3 2018, opening 75 new positions and adding to 2,456 existing holdings. Its largest new stake was KKR & Co: 895,988 shares worth $24.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $156M trimmed.
- Charles Schwab's largest Q3 2018 buy was KKR & Co: 895,988 shares worth $24.4M.
- Charles Schwab added most to Microsoft in Q3 2018, an estimated $175M increase.
- Charles Schwab's biggest Q3 2018 reduction was Apple, cutting an estimated $156M.
- Charles Schwab fully exited GGP Inc. in Q3 2018, selling an estimated $135M.
- Charles Schwab's ten largest holdings make up 15% of its $150B portfolio in Q3 2018.
- Charles Schwab opened 75 new positions and closed 56 in Q3 2018.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $150B.
Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.